Rossari Biotech Ltd. IPO Subscription Period From 13th July To 15th July 2020:
To begin with, the Rossari Biotech Ltd. embodied in 2009. Certainly, the company came up as a manufacturer of textile specialty chemicals. On the other hand, it provides customized solutions to the apparel and also animal & poultry feed. The company plans to enter the market through its initial public offering. The IPO subscription period will start on 13th July and it will end on 15th July 2020.
Rossari Biotech Ltd. IPO Details:
|Bid Period||13th July to 15th July 2020|
|IPO Type||Book Built Issue IPO|
|IPO Size||1,16,82,033 Eq Shares of Rs. 2 (aggregating up to Rs. 496.49 cr)|
|Offer for Sale||1,05,00,000 Eq Shares of Rs. 2 (aggregating up to Rs. 500 cr)|
|Face Value||Rs. 2 per Equity Share|
|IPO Price||Rs. 423 to Rs. 425 Per Equity Share|
|Market Lot||35 Shares|
|Minimum Order Quantity||35 Shares|
|Listing At||BSE, NSE|
The company introduced a ‘Book Built Issue IPO‘ type initial public offering with the face value of Rs. 10 per equity share. Initially, Rossari Biotech provided an issue size of 1,16,82,033 equity shares with an aggregating of Rs. 496.49 cr. Similarly, the price band of the issue from Rs. 423 to Rs. 425 per equity share.
The market lot and minimum order quantity of the issue is 35 shares per each. If any investor should invest in this company with a minimum investment amount of Rs. 14,875 (1 lot=35 shares). Also, the maximum investment amount of Rs. 1,93,375 (13 lot= 455 shares).
The promoters of the company are Mr. Edward Menezes and Mr. Sunil Chari.
|Pre Issue Share Holding||95.06%|
|Post Issue Share Holding|
The object of the company, it plans to utilize the IPO raised amount for the working capital requirements, and issue expenses. The company shares will be list on both the National Stock Exchange and Bombay Stock Exchange.
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai-400083
Phone: +91-22-4918 6270
Email: [email protected]
Disclaimer: This post is just information about the IPO. It does not give any advice or recommendation. Please read the offer document carefully and consult your advisor before investing.